MyAverix Finance
HK · Healthcare
Zhongzhi Pharm Hldg Ltd (3737)
Drug Manufacturers - Specialty & Generic
Zhongzhi Pharm Hldg Ltd (3737) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $658.12M, P/E ratio is 39.00, net margin is 1.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3737
Zhongzhi Pharm Hldg Ltd (3737) — FAQ
What is Zhongzhi Pharm Hldg Ltd's market cap?
Zhongzhi Pharm Hldg Ltd (3737) has a reported market cap of $658.12M (data as of 2026-05-21).
What is 3737's P/E ratio?
The price-to-earnings (P/E) ratio for Zhongzhi Pharm Hldg Ltd (3737) is 39.00 (data as of 2026-05-21).
Does Zhongzhi Pharm Hldg Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zhongzhi Pharm Hldg Ltd (3737). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhongzhi Pharm Hldg Ltd in?
Zhongzhi Pharm Hldg Ltd (3737) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 3737 listed on?
3737 is listed on HK.
What is Zhongzhi Pharm Hldg Ltd's net margin?
Zhongzhi Pharm Hldg Ltd (3737) reports a net margin of 1.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.